kff employer health benefits survey 2025 glp-1 coverage The Ozempic, Semaglutide, and Problem For Employers KFF (@kff_org) • Instagram photos

Understanding of potential side effects and risks

Severe Gastrointestinal Adverse Reactions: Use of Wegovy has been associated with severe gastrointestinal reactions that are sometimes severe

The launch of oral GLP-1s coupled with lower prices and broader access (including Medicare and Medicaid coverage in the U.S.) should drive higher utilization and market penetration as more affordable and convenient options become available. Chris Schott Senior Analyst covering the U.S

A 6-week wait costs about $217 in membership fees before any medication ships

We combine physician-guided medical therapy with metabolic testing, body composition analysis, required laboratory evaluation, nutrition support and functional medicine strategies to help patients lose weight in a healthier, more sustainable way